Let’s break through T1D together

For over 50 years, we’ve fueled breakthrough research and game-changing innovation and connected members of the type 1 diabetes (T1D) community globally. As partners, we can take the T1D community even further, all while accelerating the race to cures.

Man and Woman Looking at Breakthrough T1D's Partnerships

Explore our corporate partnership programs

Create a culture of giving in the workplace.

Connect your employees with our mission and each other. 

Meet your organization’s philanthropic goals by joining our battle to find a cure.

National partners

Our focus on T1D means that everything we do creates forward momentum for the type 1 diabetes community. From research to advocacy and community support, we create new ways and bigger opportunities to drive progress. Our partnership can help accelerate breakthroughs so that everyone with T1D can live fuller, healthier lives.

Diamond Partners: Contributing more than $2,500,000 annually

Ford
Marshalls

Platinum Partners: Contributing between $1,000,000 and $2,499,000 annually

Sanofi
Wawa

Gold Partners: Contributing between $500,000 and $999,999 annually

Abbott
Medtronic
Sanmar
Food City
Novo Nordisk
HyVee
Vertex
Lilly
Elevance Health Foundation

Silver Partners: Contributing between $250,000 and $499,999 annually

Tops
Veronica Beard

Bronze Partners: Contributing between $100,000 and $249,999 annually

Amphastar Pharmaceuticals
Delta Tau Delta
Dexcom
Embecta
Floyd's Barbershop
Tandem Diabetes Care
Harris Teeter
Xeris
Insulet
Mattress Firm

Industry Advisory Panel

Breakthrough T1D’s Industry Advisory Panel (IAP) is a forum whose purpose is to develop an open dialogue and strengthen relationships with our industry partners. This includes sharing our development and organizational strategies, advocacy and research priorities, and marketing initiatives. In turn, the IAP provides members an opportunity to provide feedback on these updates as part of a collaborative and synergistic relationship with each IAP member.

Abbott
Dexcom
Embecta
Insulet
Lilly
Medtronic
Novo Nordisk
Tandem Diabetes Care
Vertex
Xeris Pharmaceuticals
Sanofi